Anti-thymocyte globulin for graft-versus-host disease prophylaxis in patients with intermediate- or high-risk acute myeloid leukaemia undergoing reduced-intensity conditioning allogeneic stem cell transplantation in first complete remission - a survey on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation.
Br J Haematol
; 184(4): 643-646, 2019 02.
Article
in En
| MEDLINE
| ID: mdl-29468648
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Remission Induction
/
Leukemia, Myeloid, Acute
/
Stem Cell Transplantation
/
Graft vs Host Disease
/
Antilymphocyte Serum
Type of study:
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
Br J Haematol
Year:
2019
Type:
Article
Affiliation country:
Israel